MoneyWorks4Me

A fair growth of 13.46% in the revenue at Rs. 296.71 millions was reported in the December 2025 quarter as compared to Rs. 261.50 millions during year-ago period.The company suffered a huge decline of -78.92% to Rs. 18.75  millions from Rs. 88.94 millions  of corresponding previous quarter.Operating Profit reported a sharp decline to 23.97 millions from 95.45 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 296.71 261.50 13.46 744.14 725.33 2.59 1116.45 1087.39 2.67
Other Income 2.61 88.02 -97.03 159.05 208.72 -23.80 241.12 148.74 62.11
PBIDT 23.97 95.45 -74.89 155.98 254.30 -38.66 283.10 230.18 22.99
Interest 0.31 1.01 -69.31 1.30 2.16 -39.81 2.66 3.89 -31.62
PBDT 23.66 94.44 -74.95 154.68 252.32 -38.70 280.44 226.29 23.93
Depreciation 6.47 5.50 17.64 18.72 16.21 15.48 22.02 19.55 12.63
PBT 17.19 88.94 -80.67 135.96 236.11 -42.42 258.42 206.74 25.00
TAX -1.56 0.00 0.00 -1.56 19.64 -107.94 61.62 38.97 58.12
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 20.98 1.13 1756.64
PAT 18.75 88.94 -78.92 137.52 216.47 -36.47 196.80 167.77 17.30
Equity 210.41 210.41 0.00 210.41 210.41 0.00 210.41 210.41 0.00
PBIDTM(%) 8.08 36.50 -77.87 20.96 35.06 -40.21 25.36 21.17 19.79
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..